Latest Growth Strategy News

Dateline Resources is poised to release its Colosseum Gold Project Bankable Feasibility Study imminently, while expanding rare earth exploration at its new Music Valley project and bolstering its balance sheet with a $50 million placement.

Alara Resources maintained steady copper-gold production at its Al Wash-hi Majaza Mine despite regional geopolitical shipping disruptions, while advancing exploration and managing ongoing legal proceedings in Oman.

Canterbury Resources has kicked off an extensive drilling campaign at its flagship Briggs Copper Project as part of a Pre-feasibility Study, while securing the Monto Project with promising copper-molybdenum resources. High-grade assays from PNG’s Ekuti Range reaffirm the company’s regional exploration potential.

Vection Technologies has reported its third straight quarter of positive operating cash flow, driven by a $30 million Defence order book and a surge in AI contracts worth $4 million across multiple sectors.

T&G Global is moving to sell its New Zealand fresh produce and Pacific Island businesses as part of a strategic pivot to concentrate on its premium Apples and VentureFruit platforms. The divestments, pending contract finalisation, mark a significant reshaping of the company’s portfolio amid shareholder shifts.

Dundas Minerals has secured $2.5 million to fund extensive drilling across its Western Australian gold portfolio, exercised its option to acquire the Rockland mining lease, and expanded the Romano project with a new exploration licence application near Gruyere.

West Wits Mining has poured its first gold at Qala Shallows, marking its transition to production, while securing substantial funding and advancing plans to scale output.

Andean Silver has delivered robust drilling results at Cerro Bayo, reinforcing resource continuity and growth prospects ahead of a June mineral resource update and ongoing restart studies.

Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.

Syrah Resources delivered a record 24kt graphite production at Balama and secured US$72 million in equity to support medium-term ramp-up and Vidalia commercialisation, navigating a complex US trade environment.

Nova Eye Medical reported a 23% rise in quarterly sales to US$5.8 million, driven by strong US growth and initial Chinese sales. EBITDA loss narrowed significantly, with positive operational EBITDA recorded.

Alcidion Group delivered positive cashflow and strong new sales in Q3 FY26, with contract expansions in the UK and Australia. The company remains on track for a significant Electronic Patient Record contract signing in May.